The Diseased Lung and Drugs

作者: Ph. Camus , L. Jeannin

DOI: 10.1007/978-3-642-69132-4_7

关键词:

摘要: Among the numerous ways by which drug-lung relationships can be discussed we chose to examine three questions:

参考文章(81)
Grant R. Wilkinson, David G. Shand, A physiological approach to hepatic drug clearance Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 377- 390 ,(1975) , 10.1002/CPT1975184377
Godleski Jj, Skornik Wa, Brain Jd, Tryka Af, Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphologic assessment. The American review of respiratory disease. ,vol. 126, pp. 1074- ,(1982) , 10.1164/ARRD.1982.126.6.1074
Gurtner Hp, Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter? Bulletin européen de physiopathologie respiratoire. ,vol. 15, pp. 897- 923 ,(1979)
Eugene Debs Robin, Extrapulmonary manifestations of respiratory disease UMI Books on Demand. ,(1978)
John R. Vane, Y. S. Bakhle, Metabolic Functions of the Lung ,(1977)
A. H. Conney, PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTION Pharmacological Reviews. ,vol. 19, pp. 317- 366 ,(1967)
Alain F. Junod, Metabolism, production, and release of hormones and mediators in the lung. The American review of respiratory disease. ,vol. 112, pp. 93- 108 ,(1975) , 10.1164/ARRD.1975.112.1.93
S Riegelman, S Vozeh, J R Powell, L Sansom, J F Thiercelin, The influence of cigarette smoking and sex on theophylline disposition. The American review of respiratory disease. ,vol. 116, pp. 17- 23 ,(2015) , 10.1164/ARRD.1977.116.1.17
Robert A. Roth, David A. Wiersma, Role of the Lung in Total Body Clearance of Circulating Drugs Clinical Pharmacokinectics. ,vol. 4, pp. 355- 367 ,(1979) , 10.2165/00003088-197904050-00002